Phase I trial of the hedgehog (Hh) inhibitor, LDE225, in combination with etoposide and cisplatin (EP) for initial treatment of extensive stage small cell lung cancer (ES-SCLC) Meeting Abstract
| Authors: | Pietanza, M. C.; Krug, L. M.; Varghese, A. M.; Fleisher, M.; Teitcher, J. B.; Holodny, A.; Sima, C. S.; Litvak, A. M.; Ng, K. K.; Patel, P. R.; Ibrahim, F.; Haughney Siller, A.; Dulko, D.; Monger, G.; Albano, M.; Moran, C. M.; Kris, M. G.; Rudin, C. M. |
| Abstract Title: | Phase I trial of the hedgehog (Hh) inhibitor, LDE225, in combination with etoposide and cisplatin (EP) for initial treatment of extensive stage small cell lung cancer (ES-SCLC) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613204060 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.7602 |
| Notes: | Meeting Abstract: 7602 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
